On ECHEMI
Home > Drugs > Cystic mastopathy
Cystic mastopathy
Cystic hyperplasia of breast, also known as chronic cystic breast disease, cystic desquamative breast hyperplasia, fibrocystic breast disease, etc. It is a disease characterized by cysts formed by highly dilated breast lobules, ductules and terminal ducts, accompanied by malformed breast structure. This disease is one of the common and frequently occurring diseases in women, more common in women aged 25 to 45. It is essentially a disorder of the normal structure of the breast caused by physiological hyperplasia and incomplete restoration. Compared with simple breast hyperplasia, this disease has coexistence of breast hyperplasia and atypical hyperplasia, and there is a risk of malignant transformation, which is the difference. It should be regarded as a precancerous lesion.
  • Site of disease:

    breast
  • Infectious :

    Not contagious
  • Frequent population:

    More common in women aged 25-45
  • Related symptoms:

    Back pain nodule cyst painless single hard lump in breast thickening of the gland in the upper outer quadrant of breast
  • Concurrent disease:

Related Drugs
Rukang Capsules
Manufacturer:

China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.

Small gold capsule
Manufacturer:

Jianmin Pharmaceutical Group Co., Ltd.

Xiaoru Sanjie Capsules
Manufacturer:

Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.

Rukang soft capsule
Manufacturer:

Xi An Daheng Pharmaceutical Co., Ltd.

Rupixiao plaster
Manufacturer:

Anhui Jinma Pharmaceutical Co., Ltd.

  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.